How effective is bevacizumab in the treatment of angiodysplasia?

No direct evidence for bevacizumab's effectiveness in angiodysplasia. Limited data hint at potential benefits in refractory cases, but variability and side effects warrant careful use.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24372943
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

How effective is bevacizumab in the treatment of angiodysplasia?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Gastrointestinal Bleeding Diagnosis and Treatment
article

How effective is bevacizumab in the treatment of angiodysplasia?

Tripdatabase
article en

Abstract

No direct evidence for bevacizumab's effectiveness in angiodysplasia. Limited data hint at potential benefits in refractory cases, but variability and side effects warrant careful use.

Zenodo (CERN European Organization for Nuclear Research)
Gastrointestinal Bleeding Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon